Free Trial

Hepion Pharmaceuticals (HEPA) Insider Trading & Ownership

Hepion Pharmaceuticals logo
$0.10 +0.01 (+5.67%)
As of 05/14/2026 03:16 PM Eastern

Hepion Pharmaceuticals (NASDAQ:HEPA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.06%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$49.79K
Number Of
Insiders Selling
(Last 3 Years)
0
Get HEPA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Hepion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HEPA Insider Buying and Selling by Quarter

Hepion Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/27/2023
Peter Wijngaard
Director
Buy50$152.50$7,625.00  
11/24/2023
Peter Wijngaard
Director
Buy50$154.50$7,725.00  
9/19/2023
Peter Wijngaard
Director
Buy20$282.00$5,640.00  
9/18/2023
Robert T Foster
CEO
Buy32$280.00$8,960.00  
9/15/2023
Peter Wijngaard
Director
Buy40$280.00$11,200.00  
9/15/2023
Robert T Foster
CEO
Buy32$270.00$8,640.00  
(Data available from 1/1/2013 forward)

HEPA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Hepion Pharmaceuticals includes Peter Wijngaard, and Robert T Foster. Learn more on insiders at HEPA.

0.06% of Hepion Pharmaceuticals stock is owned by insiders. Learn more on HEPA's insider holdings.



This page (NASDAQ:HEPA) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners